Kansas · 2025-2026 Regular Session · Bill
HB 2550: Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.
Did not advance Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Did not advance
Last official action: ·Record last updated:
Plain-language summary
HB 2550 is a bill introduced in the Kansas House on January 27, 2026. According to its official title, it concerns: Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program. Primary sponsor: Committee on Insurance. Most recent recorded action (April 10, 2026): Died in Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Committee on Insurance | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Died in Committee
- Withdrawn from House Committee on Interstate Cooperation; Referred to House Committee on Interstate Cooperation
- Introduced
- Referred to House Committee on Insurance